Home/Filings/4/0001140361-25-013471
4//SEC Filing

Colangelo Dominick 4

Accession 0001140361-25-013471

CIK 0000887359other

Filed

Apr 10, 8:00 PM ET

Accepted

Apr 11, 4:05 PM ET

Size

13.6 KB

Accession

0001140361-25-013471

Insider Transaction Report

Form 4
Period: 2025-04-09
Colangelo Dominick
DirectorPresident and CEO
Transactions
  • Exercise/Conversion

    Common Stock

    2025-04-10$2.75/sh+24,850$68,338285,204 total
  • Sale

    Common Stock

    2025-04-10$41.89/sh24,850$1,040,967260,354 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2025-04-10+24,8500 total
    Exercise: $2.75Common Stock (24,850 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2025-04-09+24,85024,850 total
    Exercise: $2.75Common Stock (24,850 underlying)
  • Sale

    Common Stock

    2025-04-09$41.11/sh24,850$1,021,584260,354 total
  • Exercise/Conversion

    Common Stock

    2025-04-09$2.75/sh+24,850$68,338285,204 total
Footnotes (4)
  • [F1]These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  • [F2]The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2024.
  • [F3]These options, representing the right to purchase 210,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 8, 2017, which was one quarter after the date on which the option was granted.
  • [F4]These options, which were awarded on February 8, 2017, would otherwise expire and become forfeitable on February 8, 2027.

Issuer

Vericel Corp

CIK 0000887359

Entity typeother

Related Parties

1
  • filerCIK 0001313403

Filing Metadata

Form type
4
Filed
Apr 10, 8:00 PM ET
Accepted
Apr 11, 4:05 PM ET
Size
13.6 KB